Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

Andrew X. Zhu, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky, Avinash R. Kambadakone, Alona Muzikansky, Hui Zheng, Jeffrey W. Clark, Thomas A. Abrams, Jennifer A. Chan, Peter C. Enzinger, Pankaj Bhargava, Eunice L. Kwak, Jill N. Allen, Sanjay R. Jain, Keith Stuart, Kerry Horgan, Susan Sheehan, Charles S. Fuchs, David P. Ryan, Dushyant V. Sahani

Research output: Contribution to journal › Article › peer-review

209 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences